Spyre Therapeutics
SYRE
SYRE
23 hedge funds and large institutions have $26.6M invested in Spyre Therapeutics in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+23
Holders Change %
–
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jennison Associates
New York
|
+$6.69M |
| 2 |
O
OrbiMed
New York
|
+$6.61M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.55M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.54M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$1.97M |
Top Sellers
No sellers this quarter
